WATSON 583 (Propafenone 225 MG)
Pill imprint WATSON 583 has been identified as Propafenone hydrochloride 225 MG.
Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 MG is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 583 (Propafenone 225 MG)
- 225 MG
- 10.00 mm
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|54569-6133||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
Propafenone hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...